26 Aug, PM

Explore how AI is transforming the delivery of healthcare and accelerating biomedical research, from optimising clinical workflows to enabling precision medicine. This track showcases the latest AI-driven solutions revolutionising care delivery, pharmaceuticals, and diagnostics.

AI enables faster and more accurate analysis of complex genomic, proteomic, and clinical datasets, powering precision diagnostics and personalised treatment strategies. This session will highlight case studies in oncology, rare diseases, and predictive risk assessment, demonstrating clinical and commercial impact.

How can regulators foster innovation while ensuring patient safety? Panelists will discuss AI validation standards, transparency, clinical accountability, and cross-border regulatory alignment in ASEAN and Singapore.

Hospitals are leveraging AI to streamline patient triage, radiology and pathology workflows, and hospital resource allocation. This session explores integration into EMRs, clinician adoption, regulatory validation, and how AI is improving patient outcomes while reducing operational costs.

Many AI initiatives stall at pilot stage. This panel explores integration, workforce adaptation, procurement, and ROI measurement to ensure AI projects deliver enterprise-wide impact across hospitals, diagnostics, and pharma.

AI is revolutionising pharmaceutical R&D by improving target identification, compound screening, and trial design, significantly reducing development timelines and costs. This session covers real-world applications, clinical validation, and the regulatory considerations of AI-enabled drug discovery.

ASEAN has the potential to become a biomedical AI hub. This panel discusses cross-border clinical trials, data-sharing frameworks, talent mobility, and regional funding mechanisms to accelerate innovation in healthtech.